Journal of Advancements in Genetic Engineering is one of the open access journals in OMICS Group. The open access policy of the journals aims at increasing the visibility and accessibility of the published content and thus providing the desirable researches to the readers. Different forms involve directly correcting a mutation, or victimization DNA that encodes a therapeutic supermolecule drug (rather than a natural human gene) to supply treatment. In factor medical care, DNA that encodes a therapeutic supermolecule is prepackaged at intervals a "vector", that is employed to urge the DNA within cells at intervals the body.OMICS Group is among best open access publishers with expert reviewers and renowned scientists in its Editorial Board. Both editors and reviewers actively participate in the peer-review process and help in completing the review process within 21 days. Apart from this OMICS Group organizes more than 3000+ International Scientific Conferences.
Last date updated on June, 2014